Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Denali Therapeutics Inc. (DNLI) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $54.06 Metrics
OS: 137.4 M -11 % ROE
Market cap: $7.43 B -15 % ROIC
Net cash: $1.19 B $8.67 per share
EV: $6.24 B

 
TTM Valuation
EBITDA
EBIT ($163) M
EPS ($1.08)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18Dec-31-17Dec-05-17
Revenues358.748.7335.726.7129.2143.20.074.5
            Revenue growth637.2%-85.5%1158.2%-79.3% 92.3%  
Cost of goods sold449.20.00.00.00.0175.50.0148.9
Gross profit-90.548.7335.726.7129.2-32.30.0-74.5
            Gross margin-25.2%100.0%100.0%100.0%100.0%-22.6% -100.0%
Research and development 265.4212.6193.4143.2 74.5 
General and administrative90.579.160.346.532.332.315.715.7
EBIT-340.7-295.862.7-213.2-46.4-46.4-90.1-90.1
            EBIT margin-95.0%-607.8%18.7%-799.1%-35.9%-32.4% -121.1%
Pre-tax income-326.0-290.671.1-197.6-36.2-36.2-88.20.0
Income taxes0.00.6-0.80.40.00.00.00.0
            Tax rate    0.0%0.0%0.0% 
Net income-326.0-291.272.0-198.0-36.2-36.2-88.2-88.2
            Net margin-90.9%-598.3%21.4%-742.1%-28.1%-25.3% -118.4%
 
Diluted EPS($2.60)($2.40)$0.64($2.07)($0.39)($0.39)($5.89)($5.89)
Shares outstanding (diluted)125.5121.5112.795.692.692.615.015.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy